Responses to ADT are generally positive in the early stages of PCa, as reflected in reduced prostate-specific antigen (PSA) in the circulation, improved osteodynia, and the stabilization of tumor burden [7]. This evidence concerns the gene KLK3 and posterior cortical atrophy.